Immuron Announces New Research Collaboration targeting Antimicrobial Resistance
Provided By GlobeNewswire
Last update: Jan 15, 2025
Highlights:
MELBOURNE, Australia, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce a new research collaboration agreement with Monash University.
Read more at globenewswire.comNASDAQ:IMRN (11/28/2025, 7:39:16 PM)
1.71
-0.04 (-2.29%)
Find more stocks in the Stock Screener
IMRN Latest News and Analysis
